Literature DB >> 27979851

Melphalan-induced cardiotoxicity: ventricular arrhythmias.

U Yanamandra1, S Gupta1, A Khadwal1, P Malhotra1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27979851      PMCID： PMC5174905          DOI： 10.1136/bcr-2016-218652

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Melphalan-induced supraventricular tachycardia: incidence and risk factors.

Authors:  Victor Feliz; Saleem Saiyad; Sumana M Ramarao; Hammad Khan; Fabio Leonelli; Maya Guglin
Journal:  Clin Cardiol       Date:  2011-04-27       Impact factor: 2.882

2.  Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older.

Authors:  L R Mileshkin; J F Seymour; M M Wolf; P Gates; E H Januszewicz; P Joyce; H M Prince
Journal:  Leuk Lymphoma       Date:  2005-11

3.  Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study.

Authors:  G L Phillips; B Meisenberg; D E Reece; V R Adams; A Badros; J Brunner; R Fenton; J Filicko; D Grosso; G A Hale; D S Howard; V P Johnson; A Kniska; K W Marshall; R Nath; E Reed; A P Rapoport; N Takebe; D H Vesole; J L Wagner; N Flomenberg
Journal:  Biol Blood Marrow Transplant       Date:  2004-07       Impact factor: 5.742
  3 in total
  1 in total

Review 1.  Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review.

Authors:  Courtney M Campbell; Avirup Guha; Tamanna Haque; Tomas G Neilan; Daniel Addison
Journal:  J Clin Med       Date:  2020-09-11       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.